Identification of Pathogens in the Neonatal Intensive Care Unit (NICU)

Pathogen Resistance Clinical Trial

Official title:

Identification of Pathogens and Their Antibiogram in the Neonatal Intensive Care Unit (NICU)

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT03077100
• Other study ID #: HYMC-0001-17
• Status: Not yet recruiting
• Phase: N/A
• First received: March 1, 2017
• Last updated: March 6, 2017
• Start date: March 2017
• Est. completion date: March 2018

Study information

• Verified date: March 2017
• Source: Hillel Yaffe Medical Center
• Contact: Samah Abu-Fanni, MD
• Email: samah_af88[@]hotmail.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

To aim of this study is to identify the pathogens and their distribution in the NICU and to determine whether empirical antibiotics are suitable for the treatment of sepsis in the unit.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 2000
• Est. completion date: March 2018
• Est. primary completion date: March 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A to 3 Months

Eligibility

Inclusion Criteria:

• Newborns with positive cultures

Exclusion Criteria:

Related Conditions & MeSH terms

• Pathogen Resistance

Intervention

Other:
• Laboratory identification of positive cultures
Laboratory identification of positive cultures

Locations

Country	Name	City	State
Israel	Hillel Yaffe Medical Center	Hadera

Sponsors (1)

Lead Sponsor	Collaborator
Hillel Yaffe Medical Center

Country where clinical trial is conducted

Israel, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Antibiogram	Positive cultures will be examined using an antibiogram and pathogens will be identified	One year